Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Autologous DNP-Modified Vaccine + Sunitinib in Stage 4 RCC
NCT00890110Phase 2Unknown
- Sponsor
- Hadassah Medical Organization
- Start
- Jun 2009
- Primary completion
- Jun 2011
- Modality
- Cell Therapies, Vaccines & Immunotherapeutics
01
Overview
A Phase 2 trial of autologous renal cell vaccine based on DNP modified cells in renal cell carcinoma (RCC), sponsored by Hadassah Medical Organization. Status: unknown.
02
Drugs
autologous renal cell vaccine based on DNP modified cells
03
Conditions
renal cell carcinoma (RCC)
Beyond the preview
Go deeper on NCT00890110.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00890110.